Menu

Amylyx Pharmaceuticals, Inc. AMLX

Full chart Compare
Set alert

Price alert · AMLX

All alert types
29.50 USD +1.88 (+6.81%)

At closeNov 6, 2026, 5:31 PM EST

29.50 0.00 0.00%

After hours · Nov 6, 5:31 PM ET

27.50 Day range 29.58
10.83 52-week range 41.14
YTD
+144.21%
1 year
+136.76%

Revenue & Expenses

Other Income → Expenses: $12.60MExpenses → Gross Loss: $37.26MExpenses → Selling, General & Admin: $114.33MExpenses → Research & Development: $104.08MExpenses → Other Operating Expenses: $59.05MIncome Tax Benefit → Expenses: $393.00KNet Loss → Expenses: $301.74MRevenue → Cost of Revenue: $87.37MOther Income$12.60MIncome Tax Benefit$393.00KNet Loss$301.74MCost of Revenue$124.63MExpenses$314.73MGross Loss$37.26MSelling, General & Admin$114.33MResearch & Development$104.08MOther Operating Expenses$59.05MRevenue$87.37M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

AMLX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
153.29M277.47M316.54M220.58M82.97M
90.40M104.08M128.19M93.45M44.04M
62.89M114.33M188.36M127.13M38.93M
-153.29M-314.73M38.80M-201.34M-82.69M
46.00K-393.00K5.03M774.00K0
-144.74M-301.74M49.27M-198.38M-87.93M
-144.74M-301.74M49.27M-198.38M-87.93M
-144.74M-301.74M49.27M-198.38M-87.93M
-144.74M-301.74M49.27M-198.38M-87.93M
-1.53-4.430.73-3.39-13.35
-1.53-4.430.73-3.39-13.35
-1.53-4.430.70-3.39-13.35
-144.69M-302.14M54.30M-197.60M-87.93M
-144.69M-302.14M54.30M-197.60M-87.93M
94.57M68.14M67.23M58.50M6.59M
94.57M68.14M69.99M58.50M6.59M